# US 8,277,795 B2 · Methods and compositions for treating motor neuron diseases comprising mesenchymal stem cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,795 B2
- Document ID: US8277795B2
- Status: Granted
- Kind: B2
- Application number: 12/302,161
- Filed: 2006-11-28
- Published: 2009-07-23
- Granted: 2012-10-02
- Earliest claimed: 2006-05-24
- Assignees: Corestem Co., Ltd.
- Inventors: Hee Tae Kim; Kyung Suk Kim; Seung Hyun Kim; Young Gyu Chai; Seong Ho Koh; Hyun Young Kim; Mi Ran Choi; Ji-Yoon Park; Kyoung Hwa Jung
- Web page: https://patentgrep.com/patent/US8277795B2

## CPC

- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A61K 38/16: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof {(enzyme inhibitors A61K38/005)}
- A61K 38/24: Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A61P 25/14: for treating abnormal movements, e.g. chorea, dyskinesia
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed herein are a composition for treating motor neuron diseases, particularly amyotrophic lateral sclerosis (ALS), using mesenchymal stem cells, and a method for treating motor neuron diseases using the composition. The composition and treatment method can provide effective therapy for motor neuron diseases, particularly for amyotrophic lateral sclerosis (ALS).

## Claims

### Claim 1

A method for treating motor neuron diseases, comprising intrathecally administering to an individual in need thereof an effective amount of a composition comprising mesenchymal stem cells, wherein the motor neuron disease is amyotrophic lateral sclerosis (“ALS”), progressive bulbar palsy (“PBP”), primary lateral sclerosis (“PLS”), or progressive muscular atrophy (“PMA”), wherein the mesenchymal stem cells express CD105 (SH2), CD29, CD44, and CD73 at 95% or more, express CD166 at 90% or more, express CD34, CD45, and HLA-DR at 5% or less, and express CDIa, CD14, CD31, and CD80 at 10% or less, and wherein mesenchymal stem cells are contained in an amount of 1×104 to 5×106 cells/ml in the composition, and wherein the individual exhibits enhanced motor ability.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the composition further comprises a diluent.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the diluent is any one of normal saline, PBS, HBSS, plasma, cerebrospinal fluid, and blood components.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the composition is used as an injectable preparation.
